Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Study Details page shows only minor formatting adjustments with no changes to core study content, including eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T20:51:51.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a new version tag (v3.2.0) while removing the old version tag (v3.1.0).
    Difference
    1%
    Check dated 2025-10-06T07:53:50.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T04:14:55.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No core content changes are evident.
    Difference
    0.1%
    Check dated 2025-09-14T22:14:15.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:36:19.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, including specific addresses in South Korea and Japan, while also removing some previous location terms and drug information. Notably, the drug information for Durvalumab has been revised to include Tremelimumab.
    Difference
    2%
    Check dated 2025-08-31T12:27:34.000Z thumbnail image

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.